The CDDF offers workshops, conferences and webinars that bring stakeholders involved in cancer drug development into a productive dialogue in a neutral, non-competitive space. The CDDF holds multiple activities and initiatives in collaboration with regulators from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) and other regulatory agencies, academic researchers from around the globe, pharmaceutical companies, and patient advocates.
The Cancer Drug Development Forum (CDDF) Spring Conference is a unique annual meeting. This multi-stakeholder, interactive 3-day conference offers plenary lectures with moderated discussions, including case studies as well as networking opportunities. In addition to the Spring conference, the CDDF organises workshops to facilitate multi-stakeholder collaboration to address topical issues in the cancer research field.